Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome-Reference-Cited by-同舟云学术

Isoprenylcysteine Carboxylmethyltransferase-Based Therapy for Hutchinson–Gilford Progeria Syndrome

Published:2021-06-27 Issue:8 Volume:7 Page:1300-1310
ISSN:2374-7943
Container-title:ACS Central Science
language:en
Short-container-title:ACS Cent. Sci.

Author:

Marcos-Ramiro Beatriz¹,Gil-Ordóñez Ana¹,Marín-Ramos Nagore I.¹²,Ortega-Nogales Francisco J.¹,Balabasquer Moisés¹,Gonzalo Pilar³⁴,Khiar-Fernández Nora¹,Rolas Loïc⁵,Barkaway Anna⁵,Nourshargh Sussan⁵,Andrés Vicente³⁴,Martín-Fontecha Mar¹,López-Rodríguez María L.¹^ORCID,Ortega-Gutiérrez Silvia¹^ORCID

Affiliation:

1. Departamento de Química Orgánica, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, E-28040 Madrid, Spain

2. CEI Campus Moncloa, UCM-UPM and CSIC, E-28040 Madrid, Spain

3. Vascular Pathophysiology Area, Centro Nacional de Investigaciones Cardiovasculares (CNIC), E-28029 Madrid, Spain

4. Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), 28029 Madrid, Spain

5. Centre for Microvascular Research, William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London EC1M 6BQ, United Kingdom

Funder

Ministerio de Ciencia, Innovaci??n y Universidades

Ministerio de Ciencia e Innovaci??n

Ministerio de Econom??a y Competitividad

???la Caixa??? Foundation

Wellcome Trust

Instituto de Salud Carlos III

Progeria Research Foundation

Pro-CNIC Foundation

CEI Moncloa

Severo Ochoa Program

Publisher